Being able to model human disorders in zebrafish allows scientists to understand the molecular basis of disease. This may ultimately increase the efficiency and power of the drug discovery process, thus bringing new medicines to the market faster and cheaper.” Dr. Roger Cone |
Accelerating Drug DiscoveryDespite several decades of extraordinary advances in biotechnology, it has become increasingly more difficult and expensive to bring new drugs to market to treat human disorders and diseases. The Znomics Drug Discovery Platform delivers an innovative approach to whole animal compound screening that is less costly, faster and more powerful than traditional single-target screening for drug discovery. The ZeneMark® Library of mutant fish lines provides foundation technology for discovering new drug targets, creating human disease models and conducting high-throughput in vivo screening in zebrafish (Danio rerio). |
Znomics NewsAugust 15, 2008 July 9, 2008 June 11, 2008 |
© Copyright Znomics, Inc. All rights reserved.